Four things to know:
1. The annual MedTech list honors companies that tackle surgical challenges in orthopedics.
2. Biologica’s main product, ProteiOS growth factor, is a soluble protein compound derived from the endosteum of allograft bone.
3. ProteiOS consists of a collection of growth factors, oxygenating peptides, collagen deposition peptides and cellular attachment peptides.
4. The product was initially launched for the orthopedic and neurosurgery markets.
More articles on biologics:
Dr. Adrian Park: Work-related injuries affecting orthopedic, spine surgeons & other specialists
Penn Medicine researchers seek to improve spinal discs’ early response to injury
Emory, Duke & more: 4 facilities participate in $13M clinical trial for knee stem cell treatment
